68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate Cancer
Status:
Completed
Trial end date:
2019-06-12
Target enrollment:
Participant gender:
Summary
This will be an open-labelled, single centre study in the UK. The study group will include 60
patients with three groups of patients being studied. Group A will consist of 20 patients who
have been newly diagnosed with primary high risk prostate cancer and are scheduled for
radical prostatectomy surgery. Group B will consist of 20 patients with a diagnosis of BCR
with previous radical prostatectomy, and are being considered for radical salvage therapy.
Group C will consist of 20 patients with a diagnosis of BCR with previous radical
radiotherapy (but no surgery), and are being considered for radical salvage therapy.